IL-38 alleviates airway remodeling in chronic asthma via blocking the profibrotic effect of IL-36γ
Clinical and Experimental Immunology · 13.12.2023 · 214 (3) · 260-274
DOI: 10.1093/cei/uxad099 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Experimental Immunology, online erschienen am 16.08.2023. Verfasst von Min Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary and Critical Care Medicine, The Third Affiliated Hospital of Sun Yat-Sen University, Institute of Respiratory Disease of Sun …. Hauptthemen laut MEDLINE: Airway Remodeling, Asthma. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Airway remodeling is a major feature of asthma. Interleukin (IL)-36γ is significantly upregulated and promotes airway hyper-responsiveness (AHR) in asthma, but its role in airway remodeling is unknown. Here, we aimed to investigate the role of IL-36γ in airway remodeling, and whether IL-38 can alleviate airway remodeling in chronic asthma by blocking the effects of IL-36γ. IL-36γ was quantified in mice inhaled with house dust mite (HDM). Extracellular matrix (ECM) deposition in lung tissues and AHR were assessed following IL-36γ administration to mice. Airway inflammation, AHR, and remodeling were evaluated after IL-38 or blocking IL-36 receptor (IL-36R) treatment in asthmatic mice. The effects of lung fibroblasts stimulated with IL-36γ and IL-38 were quantified in vitro. Increased expression of IL-36γ was detected in lung tissues of HDM-induced asthmatic mice. The intratracheal instillation of IL-36γ to mice significantly enhanced the ECM deposition, AHR, and the number of activated lung fibroblasts around the airways. IL-38 or blocking IL-36R treated asthmatic mice showed a significant alleviation in the airway inflammation, AHR, airway remodeling, and number of activated fibroblasts around airways as compared with the HDM group. In vitro, IL-36γ promoted the activation and migration of human lung fibroblasts (HFL-1). The administration of IL-38 can counteract these biological processes induced by IL-36γ in HFL-1cells. The results indicated that IL-38 can mitigate airway remodeling by blocking the profibrotic effects of IL-36γ in chronic asthma. IL-36γ may be a new therapeutic target, and IL-38 is a potential candidate agent for inhibiting airway remodeling in asthma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pulmonary and Critical Care Medicine, The Third Affiliated Hospital of Sun Yat-Sen University, Institute of Respiratory Disease of Sun Yat-Sen University, Guangzhou, Guangdong, China.
- State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou…
ORCID-Profile: Tian-Tuo Zhang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhang, M., Zhou, J. X., Huang, C. Q., Feng, K. N., Zou, X. L., Cen, J. M., Meng, P., Li, H. T., & Zhang, T. T. (2023). IL-38 alleviates airway remodeling in chronic asthma via blocking the profibrotic effect of IL-36γ. Clinical and Experimental Immunology, 214(3), 260-274. https://doi.org/10.1093/cei/uxad099
Vancouver
Zhang M, Zhou JX, Huang CQ, Feng KN, Zou XL, Cen JM, et al. IL-38 alleviates airway remodeling in chronic asthma via blocking the profibrotic effect of IL-36γ. Clinical and Experimental Immunology. 2023;214(3):260-274. doi:10.1093/cei/uxad099
BibTeX
@article{Zhang2023,
author = {Zhang, Min and Zhou, Jian-Xia and Huang, Chu-Qin and Feng, Kang-Ni and Zou, Xiao-Ling and Cen, Jie-Mei and Meng, Ping and Li, Hong-Tao and Zhang, Tian-Tuo},
title = {IL-38 alleviates airway remodeling in chronic asthma via blocking the profibrotic effect of IL-36γ},
journal = {Clinical and Experimental Immunology},
year = {2023},
volume = {214},
number = {3},
pages = {260--274},
doi = {10.1093/cei/uxad099}
}
EUVIMED